Suchergebnisse - "Shipa, Muhammad"

PubPharm (11)

1

Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis : Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action?

enthalten in: Modern rheumatology | 2023

von Shipa, M. | Di Cicco, M. | Balogh, E. | +5

2

SLE is not a one-size-fits-all disease

enthalten in: The Journal of experimental medicine | 2023

von Ehrenstein, M. | Shipa, M.

3

Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus : an exploratory analysis of a randomised controlled trial

enthalten in: The Lancet. Rheumatology | 2023

von Shipa, M. | Santos, L. | Nguyen, D. | +7

4

Increased erythrocyte mean corpuscular volume by methotrexate predicts clinical response in psoriatic arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Shipa, M. | Langley, L. | Sacks, B. | +5

5

Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years

enthalten in: Seminars in arthritis and rheumatism | 2022

von Shipa, M. | Heyer, N. | Mansoor, R. | +7

6

The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume

enthalten in: Rheumatology (Oxford, England) | 2022

von Shipa, M. | Yeoh, S. | Embleton-Thirsk, A. | +2

7

Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy

enthalten in: Annals of the rheumatic diseases | 2021

von Shipa, M. | Amarnani, R. | Yeoh, S. | +2

8

Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2021

von Shipa, M. | Embleton-Thirsk, A. | Parvaz, M. | +25

CommentIn: Ann Intern Med. 2021 Dec;174(12):1747-1748. - PMID 34698512

9

An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic

enthalten in: Rheumatology (Oxford, England) | 2021

von Gupta, R. | Shipa, M. | Yeoh, S. | +2

10

Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive

enthalten in: Annals of the rheumatic diseases | 2020

von Greenwood, M. | Shipa, M. | Yeoh, S. | +3

CommentIn: Ann Rheum Dis. 2023 Oct;82(10):e217. - PMID 33441299